Pharmacovigilance Flashcards

1
Q

Define adverse drug reactions

A

noxious, unintended or undesired reaction occurring at doses normally for the preventative, diagnosis, or treatment of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define adverse event

A

An unfavourable outcome that occurs during or after the use of a drug or other intervention but is NOT necessarily caused by it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define side effect

A

any unintended effect of a pharmaceutical product that occurs at doses normally used for therapeutic purposes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define pharmacovigilance

A

Science of activities related to detection, assessment, understanding, and prevention of adverse effects or any possible drug problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a signal? (context of pharmvig)

A

Alert from one of many different sources that a drug could be associated with potential hazard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When is a ADR case considered a signal?

A

When THREE cases of causal association between a drug and new ADR occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When is an ADR case considered a strong signal?

A

Five cases of ADR occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is signal of disproportionate reporting (SDR)?

A

Statistical finding that does not imply a causal relationship between a drug and the ADR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What the signal noise ratio?

A

Measure’s the difference between the signal and the noise

How likely other factors are to have contributed to the adverse advent rather than the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the three mechanisms/processes used to evaluate causal links between drugs and ADRs?

A

Operational algorithms

Expert opinion

Probabilistic approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How is operational algorithm used to evaluate causal links of ADRs?

A

Address the question of alternative etiological causes of ADR w/ yes or no and unknown answers.

Assesses successive causality criteria combined by means of scores or a decision tree

Like a survey/questionnaire

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the limitations of an operational algorithm?

A

Relies on patient’s ability to notice issue was present in part or happened after drug

Weighing determined by person (subjective) (e.g. definite ADR 9+, 5-8 is probable ADR, 1-4 is possible ADR)

Does not account for drug-drug interactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is expert opinion used to evaluate causal links of ADRs?

A

Expert opinion is typically used for orphan drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the limitations to expert opinion in the evaluation of causal links?

A

Unstructured opinion is not reproducible

Components of opinion are unstated and unquantified

Subjective, lacks standardisation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is probabilistic approach used to evaluate causal links of ADRs?

A

Uses bayesian approach and epidemiological data to calculate and estimate probability of causality

Determines/estimates likelihood of ADR with suspected drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the limitations of the probabilistic approach in the evaluation of causal links?

A

Development of probabilistic measures requires knowledge of prior odds and likelihood ratios

Requires complex calculations

17
Q

When do you report an ADR for a new drug?

A

report all suspected

18
Q

Who are the global partners in pharmacovigilance?

A

The WHO Quality Assurance and Safety: Medicine Team –> provide guidance and support on drug safety matters

Uppsala Monitoring Centre –> manage international database of ADR reports received from national centres

19
Q

Other than the global partners in PV, what are some other partners?

A

National Pharmacovigilance Centres: (TGA)

Hospitals and academia

Health professionals = success of reporting system depends on their voluntary reporting

Patients = know actual benefit and harm

20
Q

What are some challenges in reporting ADRs?

A

Failure to detect reaction due to low lvls of suspicion

Fear of legal implications, lack of training about drug therapy

Lack of clear responsibility for reporting, no financial incentive to report, unaware of reporting procedure

Fear of removal of useful drugs

21
Q

What is the ATTEND DR acronym used for?

A

Used to evaluate the causality of an ADR

It is an operational algorithm

22
Q

What does ATTEND DR stand for?

A

A- Abnormality/adverse effect = evidence for ADR subjective/objective?

T - taken (suspected drug) = did they take the drug?

T - Timeline = was ADR before or after drug was taken?

E - Evidence = do ADRs match those in literature?

N - Nothing else = other causes for ADRs? pre-existing issues?

D - Dose = does the ADR worsen with inc dose?

D- Dechallenge = does the ADR improve if the drug is removed?

R - Rechallenge = re-administration of suspected drug after dechallenge